Regulatory Filings • Mar 27, 2019
Regulatory Filings
Open in ViewerOpens in native device viewer
_________ false
| ����� ����� ��"� | 2 379 |
| KITOV PHARMA LTD | |
| Corporation no: 520031238 | 10994 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C001 ( Public ) | Reported via MAGNA: | 26/03/2019 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2019-02-026968 | Time of broadcast: 23:33 23:31:41 |
Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.
| Delay the publication of a report | _________ | _________ |
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Commission file number 001-37643 Kitov Pharma Ltd.
f20f2018_kitovpharmaltdEDGAR7_Bannerless_isa.pdf
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 SIGNATURES KITOV PHARMA LTD. By: /s/ Isaac Israel Name: Isaac Israel Title: Chief Executive Officer By: /s/ Gil Efron Name: Gil Efron Title: Chief Financial Officer March 26, 2019 | |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 19/02/2019 |
| Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 , Israel Tel: 03-9333121 , Fax: 03-5097196 | |
| E-mail address: [email protected] Company site: www.kitovpharma.com | |
| Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD, | |
| Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company: | |
| Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1 | |
| Israel |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.